TipRanks
Ironwood Pharma (IRWD)
NASDAQ:IRWD
US Market
IRWD
Ironwood Pharma
RESEARCH TOOLSreports
Want to see IRWD full AI Analyst Report?

Ironwood Pharma (IRWD) Stock Forecast & Price Target

473 Followers
See the Price Targets and Ratings of:

IRWD Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Ironwood
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IRWD Stock 12 Month Forecast

There Are No Analyst Ratings for IRWD In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

IRWD Financial Forecast

IRWD Earnings Forecast

Next quarter’s earnings estimate for IRWD is $0.32 with a range of $0.30 to $0.35. The previous quarter’s EPS was $0.31. IRWD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year IRWD has Performed in-line its overall industry.
Next quarter’s earnings estimate for IRWD is $0.32 with a range of $0.30 to $0.35. The previous quarter’s EPS was $0.31. IRWD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year IRWD has Performed in-line its overall industry.

IRWD Sales Forecast

Next quarter’s sales forecast for IRWD is $119.99M with a range of $115.25M to $122.30M. The previous quarter’s sales results were $113.04M. IRWD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year IRWD has Performed in-line its overall industry.
Next quarter’s sales forecast for IRWD is $119.99M with a range of $115.25M to $122.30M. The previous quarter’s sales results were $113.04M. IRWD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year IRWD has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on IRWD
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
07/14/26
Ironwood Pharma (IRWD) Receives a Rating Update from a Top Analyst
Wells Fargo Analyst forecast on IRWD
Mohit Bansal
Wells Fargo
Wells Fargo
$5
Hold
16.55%
Upside
Reiterated
05/05/26
Analysts Conflicted on These Healthcare Names: Dexcom (NASDAQ: DXCM), Ironwood Pharma (NASDAQ: IRWD) and Crispr Therapeutics AG (NASDAQ: CRSP)
Citizens JMP Analyst forecast on IRWD
Jason Butler
Citizens JMP
Citizens JMP
$8→$10
Buy
133.10%
Upside
Reiterated
02/26/26
Ironwood price target raised to $10 from $8 at CitizensIronwood price target raised to $10 from $8 at Citizens
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on IRWD
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
07/14/26
Ironwood Pharma (IRWD) Receives a Rating Update from a Top Analyst
Wells Fargo Analyst forecast on IRWD
Mohit Bansal
Wells Fargo
Wells Fargo
$5
Hold
16.55%
Upside
Reiterated
05/05/26
Analysts Conflicted on These Healthcare Names: Dexcom (NASDAQ: DXCM), Ironwood Pharma (NASDAQ: IRWD) and Crispr Therapeutics AG (NASDAQ: CRSP)
Citizens JMP Analyst forecast on IRWD
Jason Butler
Citizens JMP
Citizens JMP
$8→$10
Buy
133.10%
Upside
Reiterated
02/26/26
Ironwood price target raised to $10 from $8 at CitizensIronwood price target raised to $10 from $8 at Citizens
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
EHCEncompass Health
MDWDMediwound
OVIDOvid Therapeutics
ARDXArdelyx
STOKStoke Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ironwood Pharma

3 Months
Jason ButlerCitizens JMP
Success Rate
6/15 ratings generated profit
40%
Average Return
-19.86%
Copying Jason Butler's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -19.86% per trade.
1 Year
Chase KnickerbockerCraig-Hallum
Success Rate
3/16 ratings generated profit
19%
Average Return
-53.60%
Copying Chase Knickerbocker's trades and holding each position for 1 Year would result in 18.75% of your transactions generating a profit, with an average return of -53.60% per trade.
2 Years
Chase KnickerbockerCraig-Hallum
Success Rate
3/16 ratings generated profit
19%
Average Return
-56.17%
Copying Chase Knickerbocker's trades and holding each position for 2 Years would result in 18.75% of your transactions generating a profit, with an average return of -56.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IRWD Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
1
2
1
1
0
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
3
1
1
0
In the current month, IRWD has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IRWD average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

IRWD Stock Forecast FAQ

What is IRWD’s average 12-month price target, according to analysts?
Currently, no data Available
What is IRWD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IRWD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is IRWD a Buy, Sell or Hold?
      Currently, no data Available
      What is Ironwood Pharma’s price target?
      Currently, no data Available
      What do analysts say about Ironwood Pharma?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of IRWD?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.